Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Coleman

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Journal of Neurosurgery. Spine|April 20, 2006
Amelioration of spinal cord compressive injury by pharmacological preconditioning with erythropoietin and a nonerythropoietic erythropoietin derivativeGiovanni Grasso, Alessandra Sfacteria, Serhat Erbayraktar, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 4, 2011
Thyroxine is a potential endogenous antagonist of macrophage migration inhibitory factor (MIF) activityYousef Al-Abed, Christine N Metz, Kai Fan Cheng, et al.
Journal of Neuroimmunology|December 13, 2005
Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitisCostanza Savino, Rosetta Pedotti, Fulvio Baggi, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 2004
Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptorMichael Brines, Giovanni Grasso, Fabio Fiordaliso, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 5, 2008
Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietinMichael Brines, Nimesh S A Patel, Pia Villa, et al.
Scientific Reports|September 18, 2023
Publisher Correction: Refinement of an ovine-based immunoglobulin therapy against SARS-CoV-2, with comparison of whole IgG versus F(ab')<sub>2</sub> fragmentsStephen Findlay-Wilson, Linda Easterbrook, Sandra Smith, et al.
Scientific Reports|August 25, 2023
Refinement of an ovine-based immunoglobulin therapy against SARS-CoV-2, with comparison of whole IgG versus F(ab')<sub>2</sub> fragmentsStephen Findlay-Wilson, Linda Easterbrook, Sandra Smith, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 15, 2003
Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivoSerhat Erbayraktar, Giovanni Grasso, Alessandra Sfacteria, et al.
Science (New York, N.Y.)|July 13, 2004
Derivatives of erythropoietin that are tissue protective but not erythropoieticMarcel Leist, Pietro Ghezzi, Giovanni Grasso, et al.
Lancet (London, England)|July 9, 2010
Erythropoietin: not just about erythropoiesisPietro Ghezzi, Myrian Bernaudin, Myriam Bernaudinb, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Journal of Neurosurgery. Spine|April 20, 2006
Amelioration of spinal cord compressive injury by pharmacological preconditioning with erythropoietin and a nonerythropoietic erythropoietin derivativeGiovanni Grasso, Alessandra Sfacteria, Serhat Erbayraktar, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 4, 2011
Thyroxine is a potential endogenous antagonist of macrophage migration inhibitory factor (MIF) activityYousef Al-Abed, Christine N Metz, Kai Fan Cheng, et al.
Journal of Neuroimmunology|December 13, 2005
Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitisCostanza Savino, Rosetta Pedotti, Fulvio Baggi, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 2004
Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptorMichael Brines, Giovanni Grasso, Fabio Fiordaliso, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 5, 2008
Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietinMichael Brines, Nimesh S A Patel, Pia Villa, et al.
Scientific Reports|September 18, 2023
Publisher Correction: Refinement of an ovine-based immunoglobulin therapy against SARS-CoV-2, with comparison of whole IgG versus F(ab')<sub>2</sub> fragmentsStephen Findlay-Wilson, Linda Easterbrook, Sandra Smith, et al.
Scientific Reports|August 25, 2023
Refinement of an ovine-based immunoglobulin therapy against SARS-CoV-2, with comparison of whole IgG versus F(ab')<sub>2</sub> fragmentsStephen Findlay-Wilson, Linda Easterbrook, Sandra Smith, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 15, 2003
Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivoSerhat Erbayraktar, Giovanni Grasso, Alessandra Sfacteria, et al.
Science (New York, N.Y.)|July 13, 2004
Derivatives of erythropoietin that are tissue protective but not erythropoieticMarcel Leist, Pietro Ghezzi, Giovanni Grasso, et al.
Lancet (London, England)|July 9, 2010
Erythropoietin: not just about erythropoiesisPietro Ghezzi, Myrian Bernaudin, Myriam Bernaudinb, et al.
Pageof 4